Finance News – Weight Loss Drugs
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Novo Nordisk cuts sales forecasts for its once-blockbuster weight loss drugs
Novo Nordisk's lowered projections reflect ongoing challenges from increased competition and weaker global demand, which together are impacting the revenue potential of its weight...
Read Full Article →Knockoff weight loss drugs were supposed to be 'gone and illegal.' Now they're bigger than ever
Despite regulatory efforts to eliminate counterfeit weight loss medications, compounding pharmacies have found a way to continue production, resulting in sustained market demand an...
Read Full Article →Superdrug to add 25 stores as demand for weight loss drugs soars
Superdrug’s planned addition of 25 new locations this year reflects growing consumer interest in weight management medications and beauty items, contributing to its financial resil...
Read Full Article →Weight loss drugs are blowing up the U.S. trade deficit. Trump is blaming Ireland
Recent substantial increases in pharmaceutical orders by companies like Eli Lilly have contributed to the widening U.S. trade deficit, reflecting efforts to navigate anticipated di...
Read Full Article →Cigna is putting a cap on weight loss drug costs
Cigna’s new pricing limits on certain weight loss medications aim to reduce out-of-pocket expenses, potentially making these treatments more affordable and accessible for eligible...
Read Full Article →Novo Nordisk CEO steps down amid growing competition for weight loss drugs
The departure of the longstanding CEO coincides with increased market challenges in the weight management sector, potentially impacting the company's strategic direction and future...
Read Full Article →Weight loss drugs are squeezing the food industry
The rapid success of GLP-1 medications is driving substantial revenue growth for pharmaceutical companies while simultaneously reducing consumer spending and demand within the food...
Read Full Article →Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
The superior results of Eli Lilly’s medication compared to Novo Nordisk’s in the recent trial may influence market dynamics and investor confidence within the competitive obesity t...
Read Full Article →